Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Gallbladder Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
0 drugs · 0 active trials
no drug at this stage
0 drugs · 0 active trials
no drug at this stage
Data updated 9 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Gemcitabine | Phase 3 | Phase 3 | 7 | 2 | 10 | 43 | 0 | — | — | 1997-12 |
| Cisplatin | Phase 3 | Phase 3 | 7 | 2 | 8 | 25 | 0 | — | — | 2002-07 |
| Oxaliplatin | Phase 3 | Phase 3 | 3 | 1 | 3 | 18 | 0 | — | — | 1998-04 |
| Durvalumab | Phase 3 | Phase 3 | 3 | 1 | 1 | 4 | 0 | — | — | Feb 7, 2018 |
| Capecitabine | Phase 3 | Phase 3 | 2 | 0 | 3 | 14 | 0 | — | — | 2002-10 |
| Fluorouracil | Phase 3 | Phase 3 | 2 | 0 | 1 | 13 | 0 | — | — | 1998-08 |
| Nab-paclitaxel | Phase 3 | Phase 3 | 2 | 1 | 1 | 5 | 0 | — | — | 2014-12 |
| Pembrolizumab | Phase 3 | Phase 3 | 2 | 0 | 1 | 5 | 0 | — | — | Jun 14, 2017 |
| Atezolizumab | Phase 3 | Phase 3 | 2 | 1 | 1 | 4 | 0 | — | — | Oct 2, 2017 |
| Bevacizumab | Phase 3 | Phase 3 | 1 | 1 | 1 | 4 | 0 | — | — | 2004-12 |
| Everolimus | Phase 3 | Phase 3 | 0 | 0 | 1 | 3 | 0 | — | — | 2009-09 |
| Porfimer | Phase 3 | Phase 3 | 0 | 0 | 2 | 3 | 0 | — | — | 1999-03 |
| Adjuvant Chemotherapy | Phase 3 | Phase 3 | 0 | 0 | 1 | 1 | 0 | — | — | Jul 1, 2019 |
| Levoleucovorin | Phase 3 | Phase 3 | 0 | 0 | 1 | 1 | 0 | — | — | 2014-02 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.